StreetAlpha.app
Home › Stocks › CARL

Carlsmed, Inc. (CARL)

Healthcare
$17.74
▲ +2.25%
LAST CLOSE · NOV 17

Carlsmed makes personalized spine fusion surgical plans, custom implants and surgical instruments for hospitals and surgical centers. It last closed at $17.74 on Nov 17, up 2.25% on the day. The average 12-month price target from 3 analysts is $23.67 (+33.4% from the last close), with a high of $26.00 and a low of $22.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is CARL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$71.8M
+60.4% vs a year ago
Net income
−$40.1M
−55.8% margin
EPS (diluted)
−$1.13
Free cash flow
−$34.9M
−48.6% margin
Valuation
Market cap
$486.1M
27.4M shares
P/E
–
No P/E while losing money
Price to sales
6.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$35.9M
At Sep 30
Debt
$15.4M
At Sep 30
Shareholder equity
$75.7M
Shares outstanding
27.4M
At Nov 6
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: $27.2M$27.2MFY2024FY2025: $50.5M$50.5MFY2025

From CARL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Last report
Nov 10
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on CARL in the past 90 days
Average 12-month target
$23.67
▲ 33.4% upside

Based on 3 analysts who set a price target on CARL in the past 90 days. The average target is $23.67, with a high of $26.00 and a low of $22.00, compared with the last close of $17.74.

Low $22.00Avg $23.67High $26.00
Blue marker: last close $17.74
Highest target$26.00
Average target$23.67
Lowest target$22.00
Latest rating changes
Truist SecuritiesTarget raised
Nov 11Buy$20 → $23
NeedhamTarget raised
Nov 11Buy$17 → $22
BTIGTarget raised
Nov 11Buy$24 → $26
BTIGMaintained
Oct 12Buy$24
Truist SecuritiesMaintained
Aug 6Buy$20
DateFirmActionRatingPrice target
Nov 11Truist SecuritiesTarget raisedBuy$20 → $23
Nov 11NeedhamTarget raisedBuy$17 → $22
Nov 11BTIGTarget raisedBuy$24 → $26
Oct 12BTIGMaintainedBuy$24
Aug 6Truist SecuritiesMaintainedBuy$20
Loading…

Technical Analysis

CARL · as of the Nov 17 close · updated after every close
Uptrend

The stock is 11% above its 20 day and 15% above its 50 day average. It is 29% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 60). The nearest support is the Pivot S1 at $17.09, and the nearest resistance the Pivot at $17.85.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 7.5%/day
Key levels
$19.1552 week high+7.9%
$19.15Swing high (Nov 11)+7.9%
$18.50Pivot R1+4.3%
$17.85Pivot+0.6%
$17.74Last close
$17.09Pivot S1−3.7%
$15.7020 day average−11.5%
$15.0550 day average−15.2%
$14.72Swing low (Sep 11)−17.0%
$14.24100 day average−19.7%
$12.60200 day average−29.0%
$8.5052 week low−52.1%
Indicators
RSI (14)60.00Strong, overbought above 70Neutral
MACD0.73Above its signal lineBullish
Stochastic66.0Middle of its rangeNeutral
ADX (14)24.6Weak trend
Williams %R-27.5Oversold below −80, overbought above −20Neutral
CCI (20)150.9Oversold below −100, overbought above 100Overbought
Rate of change+23.2%Change over 10 sessionsBullish
ATR (14)$1.33Typical daily range, 7.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for CARL

What happened before

See how CARL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in CARL in the last 90 days.

Loading…

See today’s whale options flow across the market →

CARL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲57 buying vs 27 selling
  • ▲Held by funds +2.2 pts
  • ▲Funds holding +13
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding8875+17.3%
In funds' top 1000–
Held by funds23.1%20.9%+2.2 pts
New / increased18 / 3923 / 33+1.8%
Reduced / sold out22 / 511 / 13+12.5%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CARL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CARL is in one of them and how their past CARL trades turned out.

CARL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CARL in an article yet. Here's the latest on the wider market.

About Carlsmed

Carlsmed is a medical technology company based in Carlsbad, California. Its aprevo Technology Platform uses software and AI algorithms to create personalized surgical plans for spine fusion surgery. The platform includes custom fit spinal implants and surgical instruments for lumbar and cervical procedures. The products are sold to hospitals and ambulatory surgical centers through a direct sales team and independent sales agents, and the platform is marketed to surgeons.

Headquarters
Carlsbad, CA